SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL
MORSY, S., ISMAIL, M., GHALLAB, M. (2021). SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL. EKB Journal Management System, 51(2), 365-370. doi: 10.21608/jesp.2021.193317
SALWA M. MORSY; MOUSA A. M. ISMAIL; MARWA M. I. GHALLAB. "SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL". EKB Journal Management System, 51, 2, 2021, 365-370. doi: 10.21608/jesp.2021.193317
MORSY, S., ISMAIL, M., GHALLAB, M. (2021). 'SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL', EKB Journal Management System, 51(2), pp. 365-370. doi: 10.21608/jesp.2021.193317
MORSY, S., ISMAIL, M., GHALLAB, M. SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL. EKB Journal Management System, 2021; 51(2): 365-370. doi: 10.21608/jesp.2021.193317